Before and After: What We Learned About the “Hemisphere” Program After Suing the DEA

Before and After: What We Learned About the “Hemisphere” Program After Suing the DEA By Dave Maass As the year draws to a close, so has EFF’s long-running Freedom of Information Act lawsuit against the Drug Enforcement Agency about the mass phone surveillance program infamously known as “Hemisphere.” We won our case and freed up tons of records. (So did the Electronic Privacy Information Center.) The government, on the other hand, only succeeded in dragging out the fake secrecy. In late 2013, right as the world was already reeling from…

Read More

DEA Grants Pharmaceutical Company Monopoly on Medical CBD

DEA Grants Pharmaceutical Company Monopoly on Medical CBD By Carey Wedler News circulated recently that the DEA had rescheduled cannabidiol (CBD), the nonpsychoactive ingredient in cannabis, but the technicalities of the agency’s decision actually show their ruling is highly restrictive. The decision concerned a recently FDA-approved pharmaceutical version of CBD, produced by GW Pharmaceuticals. Due to the federal government’s continued prohibition of cannabis, Epidiolex was prohibited from going to market unless the DEA rescheduled CBD. That’s what the agency did, leading some to believe that “since this FDA-approved medication is…

Read More

DEA Plans to Expand License Plate Surveillance Program

DEA Plans to Expand License Plate Surveillance Program By Michael Maharrey The U.S. Drug Enforcement Agency (DEA) plans to expand a surveillance program that tracks the location of millions of everyday people through pictures of their license plates. According to federal contracting data, the DEA will expand the footprint of its license plate tracking program with automatic license plate readers (ALPRs) connected to trailer-mounted speed displays. According to the contract announcement, the DEA will make a sole source award to RU2 Systems Inc. RU2 Systems Radar Speed Display Trailers, are retrofitted as…

Read More